Clinical value of the ankle-brachial index in patients at risk of cardiovascular disease but without known atherothrombotic disease: VITAMIN study;Valor de la determinación del índice tobillo-brazo en pacientes de riesgo vascular sin enfermedad aterotrombótica conocida: Estudio VITAMIN

Revista Espanola de Cardiologia

Volumn 59, Issue 7, 2006, Pages 662-670

  Manzano, Luiz ^a   García Diaz, Juan de D ^b   Gómez Cerezo, Jorge ^c   Mateos, Javier ^d   del Valle, Francisco J ^e   Medina Asensio, Jesús ^e   Viejo, Luis F ^f   Fernández Ballesteros, Ángel ^g   Solis, Javier ^g   Herrero Domingo, Almudena ^h   Ferreira, Eva ^h   Sánchez Fuentes, Demetrio ⁱ   Barragán, José M ⁱ   González Moraleja, Julio ^f   Vargas, Juan A ^j   López Jiménez, Manuel ^k   Zamora, Javier ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL VIRGEN DE LA SALUD   (Spain)

^g HOSPITAL SEVERO OCHOA   (Spain)

^h HOSPITAL GENERAL DE SEGOVIA   (Spain)

ⁱ HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^j HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^k HOSPITAL DE MÓSTOLES   (Spain)

more..

Author keywords

Ankle brachial index; Atherosclerosis; Diabetes mellitus; Peripheral arterial disease; Risk factors

Indexed keywords

ANTITHROMBOCYTIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL METHOD; PATHOPHYSIOLOGY; PATIENT SELECTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 33748472961     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091367     Document Type: Article

References (24)

1. Viles-González JF, Fuster V, Badimón JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004;25:1197-207.
2. Velasco JA, Cosín J, Maroto JM, Muñiz J, Casasnovas JA, Plaza I, et al Guías de práctica clínica de la Sociedad Española de Cardiología en prevención cardiovascular y rehabilitación cardiaca. Rev Esp Cardiol. 2000; 53:1095-120.
3. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovás J, Cordón F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61.
4. Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation. 2002;105:886-92.
5. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163: 884-92.
6. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608-21.
7. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol. 2005;25:1463-9.
8. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286: 1317-24.
9. Curb JD, Masaki K, Rodríguez BL, Abbott RD, Burchfiel CM, Chen R, et al. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1996;16:1495-500.
10. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18:185-92.
11. Hooi JD, Stoffers HE, Kester AD, Rinkens PE, Kaiser V, Van Ree JW, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998;16:177-82.
12. Wattanakit K, Folsom AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL, et al. Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2005;180:389-97.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
14. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45:1101-9.
15. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
16. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-45.
17. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131:115-25.
18. Lange S, Diehm C, Darius H, Haberl R, Allenberg JR, Pittrow D, et al. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes. Exp Clin Endocrinol Diabetes. 2004;112:566-73.
19. Ogren M, Hedblad B, Engstrom G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the Population Study «Men Born in 1914» from Malmo, Sweden. Eur J Vasc Endovasc Surg. 2005;29:182-9.
20. Antonopoulos S, Kokkoris S, Stasini F, Mylonopoulou M, Lepeniotis G, Mikros S, et al. High prevalence of subclinical peripheral artery disease in Greek hospitalized patients. Eur J Intern Med. 2005;16:187-91.
21. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25:17-24.
22. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733-9.
23. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes FG, Isselbacher EM, McCullough PA, et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation. 2004; 109:2605-12.
24. Vicente I, Lahoz C, Taboada M, García A, San Martín MA, Terol I, et al. Prevalencia de un índice tobillo-brazo patológico según el riesgo cardiovascular calculado mediante la función de Framingham. Med Clin (Barc). 2005; 124:641-4.